Inhibitory Effects of Antipsychotics on Carbachol-Enhanced Insulin Secretion From Perifused Rat Islets
Authors:
- 1 May 2005
- journal article
- Published by American Diabetes Association in Diabetes
- Vol. 54 (5) , 1552-1558
Abstract
Treatment with the atypical antipsychotics olanzapine and clozapine has been associated with an increased risk for deterioration of glucose homeostasis, leading to hyperglycemia, ketoacidosis, and diabetes, in some cases independent of weight gain. Because these events may be a consequence of their ability to directly alter insulin secretion from pancreatic β-cells, we determined the effects of several antipsychotics on cholinergic- and glucose-stimulated insulin secretion from isolated rat islets. At concentrations encompassing therapeutically relevant levels, olanzapine and clozapine reduced insulin secretion stimulated by 10 μmol/l carbachol plus 7 mmol/l glucose. This inhibition of insulin secretion was paralleled by significant reductions in carbachol-potentiated inositol phosphate accumulation. In contrast, risperidone or ziprasidone had no adverse effect on cholinergic-induced insulin secretion or inositol phosphate accumulation. None of the compounds tested impaired the islet secretory responses to 8 mmol/l glucose alone. Finally, in vitro binding and functional data show that olanzapine and clozapine (unlike risperidone, ziprasidone, and haloperidol) are potent muscarinic M3 antagonists. These findings demonstrate that low concentrations of olanzapine and clozapine can markedly and selectively impair cholinergic-stimulated insulin secretion by blocking muscarinic M3 receptors, which could be one of the contributing factors to their higher risk for producing hyperglycemia and diabetes in humans.Keywords
This publication has 46 references indexed in Scilit:
- Effects of muscarinic receptor type 3 knockout on mouse islet secretory responsesBiochemical and Biophysical Research Communications, 2004
- Consensus Development Conference on Antipsychotic Drugs and Obesity and DiabetesDiabetes Care, 2004
- Adverse Metabolic Effects Associated with Atypical AntipsychoticsDrugs, 2004
- Olanzapine Induces Insulin ResistanceThe Journal of Clinical Psychiatry, 2003
- Antipsychotic-Induced Type 2 Diabetes: Evidence From a Large Health Plan DatabaseJournal of Clinical Psychopharmacology, 2003
- Ziprasidone Alternative for Olanzapine-Induced HyperglycemiaAmerican Journal of Psychiatry, 2002
- Activation of the Parasympathetic Nervous System Is Necessary for Normal Meal-Induced Insulin Secretion in Rhesus MacaquesThe Journal of Clinical Endocrinology & Metabolism, 2001
- Induction of insulin resistance by cholinergic blockade with atropine in the catJournal of Autonomic Pharmacology, 1995
- Establishment of 2-mercaptoethanol-dependent differentiated insulin- secreting cell linesEndocrinology, 1992
- Altered balance in the autonomic nervous system in schizophrenic patientsClinical Physiology and Functional Imaging, 1988